Eric Halioua, President & CEO of PDC*line Pharma will present the company at the World Immunotherapy Congress USA 2019 taking place March 4th, in the Grand Hyatt, San Diego (USA). 👉 Don’t forget to...

Events

PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer...

Press releases

Eric Halioua, President & CEO of PDC*line Pharma will be spaker in the Cell & Gene Therapy Innovation Leaders Summit organized, 6th - 7th Feb 2019 at Movenpick Hotel Potsdamer Platz Berlin (Germany)....

Events

#JPM2019- The PDC*line Pharma management team will be present in full force in San Francisco during the JP Morgan Conference 2019!

Meet our CEO Eric Halioua, our CSO Joel Plumas and our COO Laurent...

Events

Eric Halioua, President & CEO of PDC*line Pharma will be a panelist at Sachs Forum 2018, Basel.

Events

Eric Halioua, President & CEO of PDC*line Pharma will present the company at Bio€quity Europe, May 14 – 16, 2018 in Ghent, Belgium. Flanders.bio’s flagship event knowledge for growth will be organized...

Events

PDC*line Pharma CEO and COO will be in Amsterdam (The Netherlands), March 12–14, 2018 for the BIO-EUROPE SPRING 12th annual international partnering conference. Contact us for a face to face meeting...

Events

Eric Halioua, President & CEO of PDC*line Pharma will present the company at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event organized, Feb. 26, 2018 in Hilton Zurich...

Events

Eric Halioua, President & CEO of PDC*line Pharma will be a panelist in the Advances in Cell & Gene Therapies round table at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event...

Events

PDC*line Pharma CEO and COO will be in San Francisco (USA) during the JP Morgan conference, January 8–10, 2017.

Events